About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5466160
Allelic
Composition
Tg(APOE-FGF23*R176Q)#Ack/0
Genetic
Background
involves: C57BL/6J * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body

craniofacial

endocrine/exocrine glands
• parathyroids become progressively enlarged over time
• secondary hyperparathyroidism

hematopoietic system

homeostasis/metabolism
• serum calcium levels are slightly diminished
• urinary calcium excretion is decreased, indicating increased renal tubular calcium reabsorption in response to circulating parathyroid hormone (PTH)
• urinary calcium excretion is decreased, indicating increased renal tubular calcium reabsorption in response to circulating parathyroid hormone (PTH)
• decrease in renal tubular reabsorption of phosphate
• low serum levels of 1,25-dihydroxyvitamin D3
• increase in serum alkaline phosphatase activity

immune system
• mutants exhibit mineralizing enthesopathy of the Achilles insertion (abnormal bony projections at the attachment of the tendon) as indicated by an expansion of type II collagen expressing mineralizing fibrochondrocytes in the Achilles insertion into the posterior and medial processes of the calcaneus at 12 weeks of age
• mutants exhibit mineralizing enthesopathy of plantar facial insertion (abnormal bony projections at the attachment of the ligament) as indicated by an expansion of type II collagen expressing fibrochondrocytes at the plantar fascia ligament attachment

limbs/digits/tail

renal/urinary system
• urinary calcium excretion is decreased, indicating increased renal tubular calcium reabsorption in response to circulating parathyroid hormone (PTH)
• urinary calcium excretion is decreased, indicating increased renal tubular calcium reabsorption in response to circulating parathyroid hormone (PTH)
• decrease in renal tubular reabsorption of phosphate

skeleton
• mutants exhibit mineralizing enthesopathy of the Achilles insertion (abnormal bony projections at the attachment of the tendon) as indicated by an expansion of type II collagen expressing mineralizing fibrochondrocytes in the Achilles insertion into the posterior and medial processes of the calcaneus at 12 weeks of age
• mutants exhibit mineralizing enthesopathy of plantar facial insertion (abnormal bony projections at the attachment of the ligament) as indicated by an expansion of type II collagen expressing fibrochondrocytes at the plantar fascia ligament attachment
• mutants exhibit a round back
• trabecular volume is increased, however mineralized trabeculae are much less numerous than in wild-type mice
• expansion of fibrochondrocytes (type II collagen expressing, showing alkaline phosphatase activity, and proteoglycan-secreting fibrochondrocytes) at the Achilles and plantar facial insertions
• expanded calcification of the entheses during the period of long bone growth
• growth plates are wider, more disorganized and less well mineralized, consistent with advanced rickets
• mutants exhibit significant unmineralized osteoid bone
• tibias of 1-2 month old mutants show wider, unmineralized growth plate and epiphyseal region of femurs show reduced mineralization
• osteomalacic changes are seen in trabecular and cortical bone due to increased amounts of unmineralized osteoid
• growth plates are wider, more disorganized and less well mineralized, consistent with advanced rickets
• low osteoclast number and the persistence of aggrecan expression and chondrocytes in the bone trabeculae indicating diminished bone resorption


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/05/2024
MGI 6.24
The Jackson Laboratory